Protagonist Therapeutics, Inc. (PTGX)
88.90
+0.34
(+0.38%)
USD |
NASDAQ |
Dec 10, 09:43
Protagonist Therapeutics EPS Diluted (Quarterly): -0.6169 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.121 |
| ADMA Biologics, Inc. | 0.1489 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Vanda Pharmaceuticals, Inc. | -0.3822 |
| Bristol Myers Squibb Co. | 1.079 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -39.34M |
| Revenue (Quarterly) | 4.712M |
| Total Expenses (Quarterly) | 44.05M |
| Enterprise Value | 4.971B |
| Gross Profit Margin (Quarterly) | 92.34% |
| Profit Margin (Quarterly) | -834.9% |
| Earnings Yield | 0.71% |
| Operating Earnings Yield | 0.33% |
| Normalized Earnings Yield | 0.7124 |